Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -4.754% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCN(CC)C(=O)Oc1nnc(SC(C)C)n1-c1ccc(Cl)cc1
b: Cc1cc(NC(=O)CSc2ncn[nH]2)no1
Answer: a. CCN(CC)C(=O)Oc1nnc(SC(C)C)n1-c1ccc(Cl)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)C(=O)Oc1nnc(SC(C)C)n1-c1ccc(Cl)cc1
CCN(CC)C(=O)Oc1nnc(SC(C)C)n1-c1ccc(Cl)cc1
[4-(4-chlorophenyl)-5-propan-2-ylsulfanyl-1,2,4-triazol-3-yl]N,N-diethylcarbamate